Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Amortizatization of Intangibles: 2022-2024

Historic Amortizatization of Intangibles for Taysha Gene Therapies (TSHA) over the last 3 years, with Dec 2024 value amounting to $1.2 million.

  • Taysha Gene Therapies' Amortizatization of Intangibles rose 5.05% to $312,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 5.88%. This contributed to the annual value of $1.2 million for FY2024, which is 2.96% up from last year.
  • Taysha Gene Therapies' Amortizatization of Intangibles amounted to $1.2 million in FY2024, which was up 2.96% from $1.2 million recorded in FY2023.
  • In the past 5 years, Taysha Gene Therapies' Amortizatization of Intangibles ranged from a high of $1.3 million in FY2022 and a low of $1.2 million during FY2023.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $1.2 million (2024), whereas its average is $1.2 million.
  • Per our database at Business Quant, Taysha Gene Therapies' Amortizatization of Intangibles dropped by 10.11% in 2023 and then climbed by 2.96% in 2024.
  • Yearly analysis of 3 years shows Taysha Gene Therapies' Amortizatization of Intangibles stood at $1.3 million in 2022, then declined by 10.11% to $1.2 million in 2023, then increased by 2.96% to $1.2 million in 2024.